Table 2. Demographic and clinical characteristics of the ten patients diagnosed with Hansen disease relapse.
| First diagnosis | Relapse | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of skin lesions | Type of lesion | R&J classification [13] | DG | MDT duration (months) | Number of skin lesions | Type of lesion | R&J classification [13] | DG | ||||
| Sex | Age | Before | End | |||||||||
| 1 | M | 31 | >20 | tubercles, infiltration | LL | 1 | 1 | 12 | 0 | - | ND | 1 |
| 2 | F | 46 | >20 | plaques | BL | 1 | 0 | 12 | 0 | - | ND | 2 |
| 3 | M | 37 | >20 | plaques, tubercles | LL | 0 | 0 | 13 | >20 | plaques | BL | 0 |
| 4 | F | 40 | >20 | nodules, infiltration | LL | 1 | 1 | 12 | 11–20 | plaques | BL | NA |
| 5 | M | 26 | 11–20 | tubercles, infiltration | LL | 0 | 0 | 12 | >20 | plaques, infiltration | LL | 0 |
| 6 | M | 18 | 6–10 | macules | BB | 0 | 0 | 12 | 6–10 | macules | BB | 0 |
| 7 | M | 23 | 11–20 | plaques | BL | 1 | 1 | 13 | >20 | tubercles, infiltration | LL | 1 |
| 8 | M | 24 | 11–20 | plaques, infiltration | LL | 0 | 0 | 12 | >20 | plaques, tubercles | LL | 2 |
| 9 | M | 53 | >20 | tubercles | LL | 0 | 0 | 12 | >20 | tubercles, infiltration | LL | 0 |
| 10 | M | 25 | >20 | plaques | BB | 0 | 0 | 12 | >20 | plaques, tubercles | BL | 0 |
m = male, f = female, LL = lepromatous leprosy, BL = borderline leprosy, ND = not defined (no skin lesions for confirmation by biopsy), MDT = multidrug therapy, R&J = Ridley and Jopling, DG = disability grade, NA = not available.